rheumatology
2012 ACR/EULAR Classification Criteria for Polymyalgia Rheumatica (PMR)
ACR/EULAR 2012 provisional criteria for classifying PMR in patients ≥50 years with new bilateral shoulder aching and elevated acute phase response. Score ≥4 (without USS) or ≥5 (with USS) = PMR classification.
References
- Dasgupta B et al. 2012 provisional classification criteria for polymyalgia rheumatica: A European League Against Rheumatism/American College of Rheumatology collaborative initiative. Arthritis Rheum. 2012;64(4):943–954.
Related
Curated clinical cross-links plus same-class fallbacks.
Drugs
- Fentanyl Transdermal Patch (Elderly Chronic Pain) · Opioid Analgesic — Transdermal Patch
- Morphine Slow-Release (Elderly Chronic Pain) · Opioid Analgesic — Modified-Release Oral
- Prednisolone (Rheumatology) · Corticosteroid (oral) — bridge/anti-inflammatory
- Dapsone · Anti-inflammatory / Antimicrobial
- Colchicine · Anti-inflammatory — Neutrophilic Dermatoses / Vasculitis
- Prednisolone (Systemic) · Systemic Corticosteroid — Acute Dermatoses
Pathways
- Cutaneous Lupus Erythematosus · BAD; EULAR
- Osteoporosis / Fragility Fracture · NOGG 2021; NICE NG147; NG224
- Arteritic AION (Giant Cell Arteritis) · RCOphth; BSR
- Osteoarthritis Hip / Knee Management · NICE NG226 (2022)
- Lupus Nephritis · EULAR/ERA-EDTA 2019; KDIGO 2024
- Rheumatoid Arthritis Management · NICE CG79 2018 / EULAR 2022
Decision support only — verify against MDCalc, NICE, or your local guideline before clinical use.